Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic.
Gambacorta N, Gasperi V, Guzzo T, Di Leva FS, Ciriaco F, Sánchez C, Tullio V, Rozzi D, Marinelli L, Topai A, Nicolotti O, Maccarrone M.
Gambacorta N, et al. Among authors: tullio v.
Eur J Med Chem. 2023 Nov 5;259:115647. doi: 10.1016/j.ejmech.2023.115647. Epub 2023 Jul 14.
Eur J Med Chem. 2023.
PMID: 37478557